Inflammatix Publishes Data Supporting TriVerity Test System Performance in Sepsis
Journal of Clinical Microbiology study validates accuracy, precision and operational usability of FDA-cleared sepsis diagnostic test.
Journal of Clinical Microbiology study validates accuracy, precision and operational usability of FDA-cleared sepsis diagnostic test.
The MeMed Severity test is a host-response technology using AI tech to predict the risk of severe outcomes in patients with suspected sepsis.
A microfluidic chip-based method assesses sepsis severity by analyzing immune cell migration: a new approach to diagnosis and prognosis.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read MoreThe Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.Â
Read MoreFind out how Cytovale’s IntelliSep test reduced cost of care and improved the efficiency of sepsis care for a large U.S. academic center.
Read MoreThis method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MoreDoctors from Norway received test results two days earlier than before when they tested a new way to analyze blood for suspected sepsis.Â
Read MoreA recent review of advances in pediatric sepsis biomarkers provides an overview of research advancements across various omics levels.
Read MoreResearchers harnessed artificial intelligence to analyze data from over 3.5 million children suffering from sepsis.
Read MoreThe Symphony System is designed to address the need for simple, reliable, rapid, near-patient sepsis testing.
Read MoreCytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Read MoreInflammatix says that the U.S. FDA has granted Breakthrough Device Designation for its TriVerity Acute Infection and Sepsis Test System.Â
Read MoreSiemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
Read MoreThe test system is intended to be used in emergency department settings in patients with suspected acute infection and sepsis.
Read MoreSteripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MoreResearch from the Penn State College of Health and Human Development found that a new blood test for sepsis could save lives and money.
Read MoreT2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
Read More